WallStreetZenWallStreetZen

NASDAQ: SCNI
Scinai Immunotherapeutics Revenue

OverviewEarningsRevenue
DividendOwnership
Scinai Immunotherapeutics revenue was N/A for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2026) ending on Mar 31, 2026 was $489.0k, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, SCNI annual revenue was $1.3M, with 99.2% growth year-over-year.

SCNI revenue history

Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%

Be the first to know when SCNI announces revenue.

SCNI Revenue History By Year

SCNI Yearly RevenueSCNI RevenueSCNI ChangeSCNI Revenue Growth
2025-12-31$1.31M$653.00k+99.24%
2024-12-31$658.00kN/AN/A
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A
2021-12-31$0.00N/AN/A
2020-12-31$0.00N/AN/A
2019-12-31$0.00N/AN/A
2018-12-31$0.00N/AN/A
2017-12-31$0.00N/AN/A
2016-12-31$0.00N/AN/A
2015-12-31$0.00N/AN/A
2014-12-31$0.00N/AN/A
2013-12-31$0.00N/AN/A
2012-12-31$0.00N/AN/A

1 of 1

Scinai Immunotherapeutics Revenue FAQ

What was SCNI's revenue last quarter?

Scinai Immunotherapeutics (NASDAQ: SCNI) reported Q1 2026 revenue of $489.00 thousand up 16.55% year over year. In the same quarter last year, Scinai Immunotherapeutics's revenue was $586.00 thousand.

What was Scinai Immunotherapeutics's revenue in 2025?

Scinai Immunotherapeutics's annual revenue for the twelve months ending Dec 31, 2025 was $1.31 million, a 99.24% increase year over year.

How much does Scinai Immunotherapeutics make in a day?

Based on Scinai Immunotherapeutics annual revenue for the past five years, SCNI makes an average of $1,078.90 per day.

What was Scinai Immunotherapeutics's annual revenue growth in the past year?

As of Q3 2026, Scinai Immunotherapeutics's revenue has grown null year over year. Scinai Immunotherapeutics's revenue in the past year totaled N/A.

How much does Scinai Immunotherapeutics make in a year?

Scinai Immunotherapeutics's revenue by year for the past five years is:
  • Scinai Immunotherapeutics's revenue for the twelve months ending Dec 31, 2025 was $1.31 million, a 99.24% increase year over year.
  • Scinai Immunotherapeutics's annual revenue for Dec 31, 2024 was $658.00 thousand, a Infinity% increase from 2023.
  • Scinai Immunotherapeutics's annual revenue for 2023 was $0.00, a N/A decrease from 2022.
  • Scinai Immunotherapeutics's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
  • Scinai Immunotherapeutics's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.